Premium
Serum angiopoietin‐2 level as a novel potential biomarker in oral lichen planus
Author(s) -
Bessar Hagar,
Hammad Noha M.,
Ismail Tawhed,
Teama Mohamed AbdElkader,
Youssef Ayman
Publication year - 2021
Publication title -
journal of cosmetic dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.626
H-Index - 44
eISSN - 1473-2165
pISSN - 1473-2130
DOI - 10.1111/jocd.13926
Subject(s) - oral lichen planus , angiopoietin 2 , angiogenesis , medicine , biomarker , angiopoietin , vascular endothelial growth factor , disease , pathology , gastroenterology , immunology , biology , vegf receptors , biochemistry
Background Lichen planus is a common chronic cutaneous inflammatory disease. Recent advances evidenced that angiogenesis is tightly connected to it. More recently, the endothelial specific growth factor angiopoietin‐2 has been clarified to interact with vascular endothelial growth factor. Angiopoietin‐2 level has not been investigated in lichen planus. Aim To evaluate serum level of angiopoietin‐2 in cutaneous and oral lichen planus. Methods Ninety patients were investigated, 45 patients with lichen planus. In addition to forty‐five healthy control, the activity of the disease was estimated at the time of examination. The serum level of angiopoietin‐2 had been estimated by enzyme‐linked immunosorbent assay. The relationships between angiopoietin‐2 serum level and disease severity, type of lichen, and visual analogue scale score (VAS) were determined. Results The serum levels of angiopoietin‐2 were substantially higher in patients with both cutaneous and oral lesions than patients with cutaneous lichen planus only ( P < .001). Conclusions Serum angiopoietin‐2 is elevated in patients compared with normal subjects and is correlated with the presence of oral lesions and disease severity, that reflects its role in angiogenesis and inflammation, and angiopoietin‐2 serum level could be a potential marker for monitoring the oral lichen to identify possible malignant transformation.